This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

From Research Labs To Doctors' Offices, Health Care Providers At Lilly Play Important Role In Bringing New And Innovative Medicines To Patients

INDIANAPOLIS, May 20, 2013 /PRNewswire/ -- The many health care providers working at Eli Lilly and Company (NYSE:LLY) − including doctors, nurses, and pharmacists − play a vital role in bringing new and innovative medicines to patients. From research labs to doctors' offices, these Lilly employees bring unique insights about patients, and ensure that patients remain at the center of drug discovery and development, as highlighted in a new video released today by the company.

"To deliver great medical outcomes, you must have a deep understanding of the people you are treating," said Dr. Brad Woodward, US Medical Leader for Lilly Bio-Medicines. "Our diverse pool of medical professionals contributes virtually every step of the way – from drug discovery and FDA approval to ongoing patient and provider education – all while keeping the patient at the center of everything we do."

The depth and breadth of medical expertise at Lilly extends broadly, to clinical research, bioethics, regulatory, medical information, quality assurance, epidemiology and beyond. That medical reach extends beyond company walls and into the healthcare community, where Lilly health care providers partner and collaborate with renowned scientific organizations, researchers and advocacy and medical associations, bringing together the brightest minds and driving innovation with the latest technological tools to find answers to some of the most urgent unmet medical needs.  

Health care providers working at Lilly include more than:
  • 500 physicians
  • 700 pharmacists
  • 1,400 scientists

For more information on the many ways health care providers that work at Lilly help keep the focus on patients, watch the video at:

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs